RSV Expert Meeting 2026

A/Prof Hannah Moore OAM is an infectious disease epidemiologist; Theme Head, Infectious Diseases and Co-Head of the Infectious Disease Epidemiology team at The Kids Research Institute Australia. She is also an Associate Professor within the School of Population Health, Curtin University and an Adjunct Associate Professor at University of Western Australia. She is currently a Stan Perron Charitable Foundation Fellow and has received further funding from the Future Health Research and Innovation Fund through the WA Near-miss Awards program.

Her passion for research involves using population-based data to investigate how to recognise, prevent and reduce serious respiratory and other infectious diseases in children through estimating burden of disease and evaluating the effectiveness of vaccination programs. She has developed expertise in the epidemiology of Respiratory Syncytial Virus (RSV) in young children, where her research was pivotal in WA Governments’ decision to establish the first and most comprehensive RSV infant immunisation program in the nation.

Raising awareness of RSV, understanding community burden and evaluating the impact of prevention measures is now a major focus of her research program, partly funded by a $2.5M Perron Program Grant. She has previously contributed to state and national influenza vaccination policy.

In 2020 A/Prof Moore joined the Strep A Vaccine Global Consortium (SAVAC) to increase knowledge and awareness of the global burden of Group A Streptococcal diseases. She now holds an activity lead position in the US$11M-funded SAVAC 2.0.

A/Prof Moore has been awarded >$19M in competitive research grants, co-authored 150 papers, was TEDxPerth 2018 speaker, recipient of a WA Young Tall Poppy Award (2013) and the WA Premiers Science Early Career Scientist Award (2015). In 2024, she was honoured with a Medal of the Order of Australia for her service to epidemiology as a researcher.

Dr Ushma Wadia is a consultant paediatrician with specialisation in immunisation and infectious diseases at Perth Children’s Hospital and Fiona Stanley Hospital, and medical lead at the Vaccine Trials Group within the Wesfarmers Centre of Vaccines and Infectious Diseases, The Kids Research Institute Australia. Dr Wadia has extensive experience in clinical and research vaccinology which allows patient, family and community engagement to enhance vaccine confidence, vaccine optimisation and uptake.

She is undertaking a PhD “Effectiveness of Respiratory Syncytial Virus (RSV) Prevention Strategies in Australian Children.” 

Dr Wadia’s published results for the 2024 RSV program in WA provides the first real world effectiveness evidence demonstrating nirsevimab effectiveness against RSV hospitalisation in Australia.

Stephen Lambert is a public health physician and medical epidemiologist who works part time for both Queensland Health and the National Centre for Immunisation Research and Surveillance. Stephen has worked in public health and been involved in vaccine preventable diseases research for over 25 years. Stephen enjoys gardening, particularly failing to grow exotic Western Australian banksias in Queensland, walking his dog, and listening to Sufjan Stevens music.

Professor Charles Feldman is currently Emeritus Professor, Department of Internal Medicine, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa, and Honorary Consultant (non-clinical) Monash Health, Melbourne, Australia. He was previously Professor of Pulmonology and Chief Physician at the Charlotte Maxeke Johannesburg Academic Hospital and the University of the Witwatersrand, between 1995 and 2017. Professor Feldman’s research interest is in the field of community-acquired pneumonia, particularly pneumococcal pneumonia, as well as in the role of vaccines in the prevention of vaccine-preventable respiratory tract infections in adults. Professor Feldman has been active on several national and international scientific committees. He was on two separate occasions the President of the South African Thoracic Society. He was elected as a Fellow of the European Respiratory Society in 2014 and the American Thoracic Society in 2017 in recognition of his contributions to the field of respiratory medicine. In 2018 he received the Platinum Gold Medal from the South African Medical Research Council for a lifetime of research in human health. In 2021, the University of Pretoria (UP) bestowed an honorary Doctor of Medicine degree (honoris causa) on Professor Feldman for his significant contribution to the field of pneumococcal respiratory infections. Professor Feldman has presented at numerous international meetings and congresses, has more than 400 publications in international literature and more than 16000 citations, and is a National Research Foundation (SA) rated Scientist.

Dr Sarah Chu graduated from the University of Queensland in 2004 with a Bachelor of Medicine and Bachelor of Surgery. She is a member of the International Society of Travel Medicine and has a Certificate in Travel Health; she enjoyed providing travel medicine services at The Travel Doctor TMVC Brisbane before COVID-19 and is an accredited Yellow Fever doctor. In addition to being awarded a Fellowship from the Royal Australian College of General Practitioners, she is a Fellow of The Australasian College of Tropical Medicine, Fellow of The Australasian College of Tropical Medicine (Faculty of Travel Medicine), Associate Member of the Faculty of Travel Medicine Royal College of Physicians and Surgeons of Glasgow; Dr Chu also holds a Diploma in Dermatology from the Australian Institute of Dermatology, and a Diploma in Child Health from Westmead Children’s Hospital and the University of Sydney. She enjoys practising yoga and is a registered level 1 yoga teacher with Yoga Australia. Dr Chu recently completed Physician Board Certification in Lifestyle Medicine with the International Board of Lifestyle Medicine. She is a Senior Lecturer for the University of Queensland and enjoys teaching the next generation of doctors-in-training.

Professor Charles Feldman is currently Emeritus Professor, Department of Internal Medicine, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa, and Honorary Consultant (non-clinical) Monash Health, Melbourne, Australia. He was previously Professor of Pulmonology and Chief Physician at the Charlotte Maxeke Johannesburg Academic Hospital and the University of the Witwatersrand, between 1995 and 2017. Professor Feldman’s research interest is in the field of community-acquired pneumonia, particularly pneumococcal pneumonia, as well as in the role of vaccines in the prevention of vaccine-preventable respiratory tract infections in adults. Professor Feldman has been active on several national and international scientific committees. He was on two separate occasions the President of the South African Thoracic Society. He was elected as a Fellow of the European Respiratory Society in 2014 and the American Thoracic Society in 2017 in recognition of his contributions to the field of respiratory medicine. In 2018 he received the Platinum Gold Medal from the South African Medical Research Council for a lifetime of research in human health. In 2021, the University of Pretoria (UP) bestowed an honorary Doctor of Medicine degree (honoris causa) on Professor Feldman for his significant contribution to the field of pneumococcal respiratory infections. Professor Feldman has presented at numerous international meetings and congresses, has more than 400 publications in international literature and more than 16000 citations, and is a National Research Foundation (SA) rated Scientist.

MBBS (Hons), FRACGP, Grad Cert Clin Teach, MPH, GAICD

Dr Anita Muñoz worked as a Clinical Editor and Clinical Advisor for 6 years with North Western Melbourne PHN through which a passion for health system improvement, innovation, sustainability, and equity emerged. She sees general practice as the key to a rational health system that produces better outcomes for patients and practitioners alike. Anita Muñoz is a GP in private practice in Melbourne’s CBD and has a dedication to evidence-based medicine, lifelong learning, and promoting the role of general practice in the health of patients, communities and in public health more broadly.

Anita has held advisory positions with Better Care Victoria and Safer Care Victoria and has been a medical educator for over 9 years. She is particularly preoccupied with the wellbeing and experience of general practice registrars, and of securing a high-quality general practice workforce for the future.

Priscilla Singh is a Registered Midwife and Clinical Nurse Consultant in Infection Prevention and Control. She holds a Master of Infection Prevention and Control from Griffith University (completed in March 2024), alongside postgraduate qualifications in immunisation and a Certificate IV in Training and Assessment.

Priscilla is an Executive Committee Member of the Immunisation Nurse Special Interest Group (INSIG) Inc. and actively immunises for her local council. She contributes to research governance through her service on several research ethics committees, including those at Monash University and St John of God Healthcare.

During the COVID-19 pandemic, Priscilla played a pivotal role in the South East Public Health Vaccination Program (2021–2022) and was deployed to Fiji as the Infection Prevention and Control lead during the outbreak.

In recognition of her outstanding contributions to public health, Priscilla was awarded the Australasian College for Infection Prevention and Control (ACIPC) 2024 Impact of the Year Award for her work in the community. In June 2025, she was also awarded the prestigious ACIPC Certified Infection Control Professional – Expert (CICP-E)certification.

Priscilla is currently undertaking a PhD, further advancing her expertise and commitment to evidence-based infection prevention and control.

A/Prof Hannah Moore OAM is an infectious disease epidemiologist; Theme Head, Infectious Diseases and Co-Head of the Infectious Disease Epidemiology team at The Kids Research Institute Australia. She is also an Associate Professor within the School of Population Health, Curtin University and an Adjunct Associate Professor at University of Western Australia. She is currently a Stan Perron Charitable Foundation Fellow and has received further funding from the Future Health Research and Innovation Fund through the WA Near-miss Awards program.

Her passion for research involves using population-based data to investigate how to recognise, prevent and reduce serious respiratory and other infectious diseases in children through estimating burden of disease and evaluating the effectiveness of vaccination programs. She has developed expertise in the epidemiology of Respiratory Syncytial Virus (RSV) in young children, where her research was pivotal in WA Governments’ decision to establish the first and most comprehensive RSV infant immunisation program in the nation.

Raising awareness of RSV, understanding community burden and evaluating the impact of prevention measures is now a major focus of her research program, partly funded by a $2.5M Perron Program Grant. She has previously contributed to state and national influenza vaccination policy.

In 2020 A/Prof Moore joined the Strep A Vaccine Global Consortium (SAVAC) to increase knowledge and awareness of the global burden of Group A Streptococcal diseases. She now holds an activity lead position in the US$11M-funded SAVAC 2.0.

A/Prof Moore has been awarded >$19M in competitive research grants, co-authored 150 papers, was TEDxPerth 2018 speaker, recipient of a WA Young Tall Poppy Award (2013) and the WA Premiers Science Early Career Scientist Award (2015). In 2024, she was honoured with a Medal of the Order of Australia for her service to epidemiology as a researcher.